Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

Giglio, Rosaria Vincenza
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.960
EU - Europa 4.454
AS - Asia 3.321
Continente sconosciuto - Info sul continente non disponibili 652
SA - Sud America 613
AF - Africa 98
OC - Oceania 26
Totale 16.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.728
IT - Italia 1.917
SG - Singapore 1.248
RU - Federazione Russa 1.025
CN - Cina 723
BR - Brasile 471
VN - Vietnam 368
HK - Hong Kong 326
DE - Germania 269
PL - Polonia 255
FR - Francia 201
GB - Regno Unito 181
FI - Finlandia 156
BD - Bangladesh 149
CA - Canada 123
JP - Giappone 107
IE - Irlanda 82
IN - India 76
SE - Svezia 60
KR - Corea 49
AR - Argentina 46
MX - Messico 46
NL - Olanda 42
IQ - Iraq 41
TR - Turchia 41
ES - Italia 39
RO - Romania 39
AT - Austria 36
UA - Ucraina 36
ID - Indonesia 25
PK - Pakistan 22
UZ - Uzbekistan 20
EG - Egitto 19
AU - Australia 18
BE - Belgio 18
CO - Colombia 17
CZ - Repubblica Ceca 17
IR - Iran 17
EC - Ecuador 16
TH - Thailandia 16
ZA - Sudafrica 16
MA - Marocco 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 14
BG - Bulgaria 13
CL - Cile 13
CH - Svizzera 12
NP - Nepal 12
MY - Malesia 11
IL - Israele 10
JM - Giamaica 10
LT - Lituania 10
PY - Paraguay 10
SA - Arabia Saudita 10
BO - Bolivia 9
CR - Costa Rica 9
PH - Filippine 9
TN - Tunisia 9
GR - Grecia 8
KE - Kenya 8
NZ - Nuova Zelanda 8
PE - Perù 8
DK - Danimarca 7
HN - Honduras 7
CI - Costa d'Avorio 6
DZ - Algeria 6
GT - Guatemala 6
PR - Porto Rico 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
NI - Nicaragua 5
PT - Portogallo 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
NG - Nigeria 4
RS - Serbia 4
TT - Trinidad e Tobago 4
JO - Giordania 3
KZ - Kazakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
GY - Guiana 2
HU - Ungheria 2
LU - Lussemburgo 2
ME - Montenegro 2
OM - Oman 2
PA - Panama 2
SD - Sudan 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
Totale 15.450
Salva come PNG Salva come JPEG
Città #
Ashburn 851
Singapore 849
San Jose 507
Fairfield 493
Chandler 477
Hong Kong 310
Palermo 282
Council Bluffs 235
Wilmington 224
Zgierz 210
Houston 200
Seattle 200
Moscow 196
Woodbridge 177
Cambridge 176
Los Angeles 159
Beijing 152
New York 140
Rome 128
Ann Arbor 121
Ho Chi Minh City 113
Dallas 111
Medford 102
Des Moines 100
Tokyo 97
Lauterbourg 95
Santa Clara 93
Milan 89
Hefei 77
Altamura 76
Dublin 76
Helsinki 70
Chicago 69
Hanoi 66
Princeton 66
San Diego 65
Lawrence 62
The Dalles 59
Boardman 55
Buffalo 54
Frankfurt am Main 54
London 49
São Paulo 47
Nuremberg 41
Toronto 38
Da Nang 34
Venice 32
Atlanta 31
Naples 31
Ludwigshafen am Rhein 30
Florence 27
Nanjing 27
Orem 26
Montreal 25
Warsaw 25
Lappeenranta 24
Phoenix 24
Brooklyn 23
Munich 21
Redwood City 21
Denver 20
Falls Church 20
Pune 20
San Paolo di Civitate 20
Turin 20
Bari 19
Columbus 19
Rio de Janeiro 18
Haiphong 17
Jinan 17
Memphis 17
Miami 17
Amsterdam 16
Bremen 16
Cagliari 16
Changsha 16
Mexico City 16
Napoli 16
San Francisco 16
Tashkent 16
Vienna 16
Baghdad 15
Bangkok 15
Boston 15
Brussels 15
Alcamo 14
Catania 14
Dearborn 14
Hebei 14
Nanchang 14
Shenyang 14
Ankara 13
Falkenstein 12
Genoa 12
Johannesburg 12
Padova 12
Paris 12
Pisa 12
Poplar 12
Salt Lake City 12
Totale 8.933
Salva come PNG Salva come JPEG
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 853
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 394
Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department 298
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 262
The Role of Nutraceuticals in Statin Intolerant Patients 257
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 246
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 236
Serum low density lipoprotein subclasses in asthma 235
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 234
A new tool for sepsis screening in the Emergency Department 233
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 228
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 223
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 222
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 221
Management of Statin Intolerance in 2018: Still More Questions Than Answers 219
Establishing sex- and age-related reference intervals of serum glial fibrillary acid protein measured by the fully automated lumipulse system 215
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 205
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 195
The effect of bergamot on dyslipidemia 195
Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis 195
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 192
Reference interval of monocyte distribution width (MDW) in healthy blood donors 181
Impact of Mycobacterium tuberculosis Infection on Human B Cell Compartment and Antibody Responses 181
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 180
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders 175
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 174
Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment 174
Nutraceuticals as an important part of combination therapy in dyslipidaemia 173
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG 173
Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis 173
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 171
Comparative analysis of biochip mosaic-based indirect immunofluorescence with enzyme-linked immunosorbent assay for diagnosing myasthenia gravis 168
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 167
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 167
Time-dependent stability of monocyte distribution width (MDW) 166
Evaluation of anti-sars-cov-2 s-rbd igg antibodies after covid-19 mrna bnt162b2 vaccine 166
Serum lipoproteins are not associated with the severity of asthma 164
Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19 163
Advances in pharmacological treatment of type 1 diabetes during pregnancy 156
COVID-19 and Alzheimer's Disease 156
NUOVE STRATEGIE TERAPEUTICHE E DIAGNOSTICHE PER IL MANAGEMENT DEL RISCHIO CARDIO-METABOLICO IN PAZIENTI CON NAFLD CON O SENZA DIABETE MELLITO TIPO 2 155
Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia 155
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders 153
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 151
Monocyte distribution width (MDW) as a reliable biomarker for urosepsis 149
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE 148
Vitamin D and Multiple Sclerosis: An Open-Ended Story 147
The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis 147
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 146
Foxp3 and gata3 polymorphisms, vitamin d3 and multiple sclerosis 145
The role of vitamin d as a biomarker in alzheimer’s disease 142
Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? 138
Natural approaches in metabolic syndrome management 137
Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases 136
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 135
Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis 134
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 132
Monocyte distribution width (MDW) kinetic for monitoring sepsis in intensive care unit 129
Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study 126
The Role of Killer Ig-like Receptors in Diseases from A to Z 125
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 125
Diabetes and colorectal cancer risk: A new look at molecular mechanisms and potential role of novel antidiabetic agents 124
Evaluation of core Biomarkers of Alzheimer’s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform 120
Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach 119
Independent validation of sepsis index for sepsis screening in the emergency department 119
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population 118
The role of serum free light chain as biomarker of Myasthenia Gravis 117
Future perspectives of the pharmacological management of diabetic dyslipidemia 116
Novel therapeutical approaches to managing atherosclerotic risk 116
Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience 114
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 113
The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis 111
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 110
Dyslipidemias 110
Biomarkers of Nutritional Status 110
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting 109
Monocyte distribution width kinetic after surgery 108
Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases 108
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives 107
Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis 107
Pharmacotherapy for gestational diabetes 105
Preliminary reference intervals of Glycated Albumin in healthy Caucasian pregnant women 105
Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease 105
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 100
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 99
Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis 97
Validation of glycated albumin reference interval in healthy Caucasian pregnant women 96
Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings 96
Thrombocytopenia and hyperinflammation are induced by extracellular histones circulating in blood 95
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 95
Evaluation of the analytical performance of three chemiluminescence serological assays for detecting anti-SARS-CoV-2 antibodies 93
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 91
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 87
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 85
Urinary urodilatin levels in patients with renal salt wasting syndrome as a possible new diagnostic marker. A pilot study 79
Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis 78
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 77
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 70
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine 68
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 66
Totale 15.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.011 0 0 124 52 44 76 50 118 107 153 115 172
2022/20231.793 135 278 56 172 143 276 137 153 199 50 112 82
2023/2024976 39 97 80 68 62 156 170 55 39 49 49 112
2024/20252.239 51 189 124 181 91 112 201 128 155 242 298 467
2025/20266.598 451 213 477 654 710 825 930 645 569 466 297 361
2026/2027803 398 282 123 0 0 0 0 0 0 0 0 0
Totale 16.124